The complexity of the CNS has caused low success rates in novel drug development for this therapeutic area.
TORONTO (PRWEB) March 19, 2021
Increasing aging populations have contributed to a rise in diagnosis of diseases of the central nervous system (CNS), such as Alzheimer’s and Parkinson’s disease. In fact, the WHO estimates that dementia alone affects 5-8% of all individuals over 60 years of age and that cases will increase by 10 million per year, rising to 82 million cases in 2030 and 152 million in 2050.
The burdens of these diseases for individuals, families and society as a whole has led to great investment from the drug development industry. Yet, the complexity of the CNS has caused low success rates in novel drug development for this therapeutic area.
In this webinar, attendees will learn about:
- Recent advances in biomarker research, both wet lab and imaging
- Why these solutions are essential for higher quality clinical study designs
- The importance of objective and clinically accurate biomarkers as a means of studying the effect of study drugs on homogenous populations
Join expert speakers from ICON, Andrew Roche, PhD, Senior Director, Scientific Affairs; Anu Bansal, MD, MHCM, Director of Medical and Scientific Affairs; and Peter Schueler, MD, Senior VP Drug Development Services - CNS, Ageing and Pain, in a live webinar on Thursday, April 8, 2021 at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Transforming CNS Drug Development with Wet Lab and Imaging Biomarker Solutions.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.